Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0305
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay ; day:14 ; month:9 ; year:2022 ; pages:1-14
Molecular biotechnology ; (14.9.2022), 1-14
- Urheber
-
Tantiwiwat, Termsak
Thaiprayoon, Apisitt
Siriatcharanon, Ake-kavitch
Tachaapaikoon, Chakrit
Plongthongkum, Nongluk
Waraho-Zhmayev, Dujduan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12033-022-00563-4
- URN
-
urn:nbn:de:101:1-2022120121412385120587
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tantiwiwat, Termsak
- Thaiprayoon, Apisitt
- Siriatcharanon, Ake-kavitch
- Tachaapaikoon, Chakrit
- Plongthongkum, Nongluk
- Waraho-Zhmayev, Dujduan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
Identification of neural feature space from spike triggered covariance expressed as a function of PRC
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
A competitive ligand-binding assay for the detection of neutralizing antibodies against dostarlimab (TSR-042)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Antibodies against outer-capsid proteins of grass carp reovirus expressed in E. coli are capable of neutralizing viral infectivity
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
Identification of neural feature space from spike triggered covariance expressed as a function of PRC
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
A competitive ligand-binding assay for the detection of neutralizing antibodies against dostarlimab (TSR-042)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Antibodies against outer-capsid proteins of grass carp reovirus expressed in E. coli are capable of neutralizing viral infectivity
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Identification of Neutralizing Monoclonal Antibodies Targeting Novel Conformational Epitopes of the Porcine Epidemic Diarrhoea Virus Spike Protein
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
Identification of neural feature space from spike triggered covariance expressed as a function of PRC
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
A competitive ligand-binding assay for the detection of neutralizing antibodies against dostarlimab (TSR-042)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus